参考文献/References:
[1] Mohanta SK,Peng L,Li Y,et al. Neuroimmune cardiovascular interfaces control atherosclerosis[J]. Nature,2022,605(7908):152-159.
[2] Hu D,Mohanta SK,Yin C,et al. Artery tertiary lymphoid organs control aorta immunity and protect against atherosclerosis via vascular smooth muscle cell lymphotoxin β receptors[J]. Immunity,2015,42(6):1100-1115.
[3] Mohanta SK,Yin C,Weber C,et al. Neuroimmune cardiovascular interfaces in atherosclerosis[J]. Front Cell Dev Biol,2023,11:1117368.
[4] Sohrabi Y,Reinecke H,Soehnlein O. Trilateral interaction between innervation,leukocyte,and adventitia:a new driver of atherosclerotic plaque formation[J]. Signal Transduct Target Ther,2022,7(1):249.
[5] Steptoe A,Kivim?ki M. Stress and cardiovascular disease[J]. Nat Rev Cardiol,2012,9(6):360-370.
[6] Tam SJ,Watts RJ. Connecting vascular and nervous system development:angiogenesis and the blood-brain barrier[J]. Annu Rev Neurosci,2010,33:379-408.
[7] Dubin AE,Patapoutian A. Nociceptors:the sensors of the pain pathway[J]. J Clin Invest,2010,120(11):3760-3772.
[8] Soehnlein O,Libby P. Targeting inflammation in atherosclerosis—From experimental insights to the clinic[J]. Nat Rev Drug Discov,2021,20(8):589-610.
[9] Coller BS. Leukocytosis and ischemic vascular disease morbidity and mortality:is it time to intervene?[J]. Arterioscler Thromb Vasc Biol,2005,25(4):658-670.
[10] Hidalgo A,Chang J,Jang JE,et al. Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury[J]. Nat Med,2009,15(4):384-391.
[11] Muller WA. Transendothelial migration:unifying principles from the endothelial perspective[J]. Immunol Rev,2016,273(1):61-75.
[12] Vestweber D. How leukocytes cross the vascular endothelium[J]. Nat Rev Immunol,2015,15(11):692-704.
[13] Akhavanpoor M,Wangler S,Gleissner CA,et al. Adventitial inflammation and its interaction with intimal atherosclerotic lesions[J].Front Physiol,2014,5:296.
[14] Brunet I,Gordon E,Han J,et al. Netrin-1 controls sympathetic arterial innervation[J]. J Clin Invest,2014,124(7):3230-3240.
[15] Yin C,Mohanta SK,Srikakulapu P,et al. Artery tertiary lymphoid organs:powerhouses of atherosclerosis immunity[J]. Front Immunol,2016,7:387.
[16] Ridker PM,Everett BM,Thuren T,et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease[J]. N Engl J Med,2017,377(12):1119-1131.
[17] Libby P. Inflammation during the life cycle of the atherosclerotic plaque[J]. Cardiovasc Res,2021,117(13):2525-2536.
[18] Gr?bner R,L?tzer K,D?pping S,et al. Lymphotoxin β receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice[J]. J Exp Med,2009,206(1):233-248.
[19] Chu C,Artis D,Chiu IM. Neuro-immune interactions in the tissues[J]. Immunity,2020,52(3):464-474.
[20] Libby P,Ridker PM,Hansson GK. Progress and challenges in translating the biology of atherosclerosis[J]. Nature,2011,473(7347):317-325.
[21] Hinterdobler J,Schott S,Jin H,et al. Acute mental stress drives vascular inflammation and promotes plaque destabilization in mouse atherosclerosis[J]. Eur Heart J ,2021,42(39):4077-4088.
[22] Juan DA,Ince LM,Pick R,et al. Artery-associated sympathetic innervation drives rhythmic vascular inflammation of arteries and veins[J]. Circulation,2019,140(13):1100-1114.
[23] Scheiermann C,Gibbs J,Ince L,et al. Clocking in to immunity[J]. Nat Rev Immunol,2018,18(7):423-437.
[24] Gibbs J,Ince L,Matthews L,et al. An epithelial circadian clock controls pulmonary inflammation and glucocorticoid action[J]. Nat Med,2014,20(8):919-926.
[25] Curtis AM,Bellet MM,Sassone-Corsi P,et al. Circadian clock proteins and immunity[J]. Immunity,2014,40(2):178-186.
[26] Gibbs JE,Blaikley J,Beesley S,et al. The nuclear receptor REV-ERBα mediates circadian regulation of innate immunity through selective regulation of inflammatory cytokines[J]. Proc Natl Acad Sci U S A,2012,109(2):582-587.
[27] Vlasov K,van Dort CJ,Solt K. Optogenetics and chemogenetics[M]. Methods Enzymol,2018,603:181-196.
[28] Poller WC,Downey J,Mooslechner AA,et al. Brain motor and fear circuits regulate leukocytes during acute stress[J]. Nature,2022,607(7919):578-584.
[29] Dutta P,Courties G,Wei Y,et al. Myocardial infarction accelerates atherosclerosis[J]. Nature,2012,487(7407):325-329.
[30] Steinman L. Lessons learned at the intersection of immunology and neuroscience[J].J Clin Invest,2012,122(4):1146-1148.
[31] Vasamsetti SB,Florentin J,Coppin E,et al. Sympathetic neuronal activation triggers myeloid progenitor proliferation and differentiation[J]. Immunity,2018,49(1):93-106.e7.
相似文献/References:
[1]李乐亮,综述,李萍,等.炎症标志物与颈动脉粥样斑块的稳定性[J].心血管病学进展,2016,(3):219.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.001]
LI Leliang,LI Ping.Stability of Inflammatory Markers and Carotid Artery Plaque[J].Advances in Cardiovascular Diseases,2016,(10):219.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.001]
[2]耿春晖 关秀茹.MicroRNA作为动脉粥样硬化的诊断生物标志物的研究进展[J].心血管病学进展,2019,(7):996.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.008]
GENG Chunhui,GUAN Xiuru.microRNA as a Diagnostic Biomarker for Atherosclerosis[J].Advances in Cardiovascular Diseases,2019,(10):996.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.008]
[3]乐健 何胜虎.前蛋白转化酶枯草溶菌素9致动脉粥样硬化的机制研究进展[J].心血管病学进展,2019,(7):1000.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.009]
YUE Jian,HE Shenghu.Advances in the mechanism of PCSK9-induced atherosclerosis[J].Advances in Cardiovascular Diseases,2019,(10):1000.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.009]
[4]武亚琳,梁斌,杨志明.NLRP3/IL-1β途径的促动脉粥样硬化作用及临床应用[J].心血管病学进展,2019,(6):943.[doi:10.16806/j.cnki.issn.1004-3934.2016.06.026]
WU Yalin,LIANG Bin,YANG Zhiming.The Role of NLRP3/IL-1in Atherosclerosis and Clinical Application[J].Advances in Cardiovascular Diseases,2019,(10):943.[doi:10.16806/j.cnki.issn.1004-3934.2016.06.026]
[5]李琦玉 ?张宁 陈婧 黄浙勇.动脉粥样硬化的抗血小板分子靶向治疗[J].心血管病学进展,2019,(5):701.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.010]
LI Qiyu,ZHANG Ning,CHEN Jing,et al.Anti-Platelet Molecular Targeted Therapy or Atherosclerosis[J].Advances in Cardiovascular Diseases,2019,(10):701.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.010]
[6]侯冬华 郝丽荣.长正五聚蛋白3在动脉粥样硬化和心血管疾病中作用研究的新进展[J].心血管病学进展,2019,(5):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
HOU Donghua H AO Lirong.The Study of Atherosclerosis and Cardiovascular Diseases with Pentapycin 3[J].Advances in Cardiovascular Diseases,2019,(10):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
[7]焦新峰 刘正霞 鲁翔.白介素-8在冠心病中的研究进展[J].心血管病学进展,2019,(8):1126.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.014]
JIAO Xinfeng,LIU Zhengxia,LU Xiang.Research Progress of Interleukin-8 in Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2019,(10):1126.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.014]
[8]徐侨 刘正霞 鲁翔.白介素22在动脉粥样硬化和2型糖尿病中的作用[J].心血管病学进展,2019,(9):1260.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.019]
XU Qiao,LIU Zhengxia,LU Xiang.IL-22 in Atherosclerosis and Type 2 Diabetes Mellitus[J].Advances in Cardiovascular Diseases,2019,(10):1260.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.019]
[9]石文坚 花蕾 孟祥光 袁义强.环状RNA在冠状动脉粥样硬化性心脏病中的研究进展[J].心血管病学进展,2019,(9):1286.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.026]
SHI Wenjian,HUA Lei,MENG Xiangguang,et al.CircRNA in Coronary Atherosclerotic Heart Disease[J].Advances in Cardiovascular Diseases,2019,(10):1286.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.026]
[10]代承忠 彭礼清 余建群 刘静 蒲华霞.双源CT血管成像评价经导管主动脉瓣置入术术前患者颈动脉斑块[J].心血管病学进展,2019,(8):1182.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.028]
DAI Chengzhong,PENG Liqing,YU Jianqun,et al.Evaluation of Carotid Arteries Plaques in Patients Referred for TAVI with Dual-source CT Angiography[J].Advances in Cardiovascular Diseases,2019,(10):1182.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.028]